Our services range from early development to the manufacture of an investigational medicinal product (IMP) / drug substance for first clinical trials in human. Service modules can be selected individually or as the whole package according to the customer’s needs. Bioconjugation services are accompanied by analytics that are individually adjusted to the needs of the bioconjugate.
Feasibility studies
Process development
Manufacturing
Contact partner
Dr. Julia Wittmann
Head of Bioconjugation
+49 30 9489 2350